跳至主要内容
临床试验/NL-OMON26562
NL-OMON26562招募中不适用

Copaxone Adherence and Care Interrelations in Patients with Relapsing Multiple Sclerosis.

MS4 Research Institute, Ubbergseweg 34, 6522 KJ Nijmegen, the Netherlands0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Indication for GA treatment in Relapsing Remitting MS (RRMS), as formulated by the regulatory authorities in the Netherlands;
  • 2. Being relapse free and having stable symptoms for at least 30 days;

排除标准

  • 1. Contra-indications for GA as defined in the Summary of Product Characteristics text;
  • 2. Hypersensitivity to glatiramer acetate or mannitol;

研究者

发起方
MS4 Research Institute, Ubbergseweg 34, 6522 KJ Nijmegen, the Netherlands

相似试验